Over a decade of experience with carboplatin therapeutic drug monitoring in a childhood cancer setting in the United Kingdom

This review describes the increasing experience of using therapeutic drug monitoring for dosing carboplatin in neonates and infants. Authors state that the collection and analysis of these data may allow the development of future dosing regimens.


British Journal of Clinical Pharmacology